- decreased bone mineral density / IMPC
- decreased circulating LDL cholesterol level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- abnormal cranium morphology / IMPC
- abnormal maxilla morphology / IMPC
- decreased body length / IMPC
- decreased body weight / IMPC
- hyperactivity / IMPC
- abnormal tooth morphology / IMPC
- decreased lean body mass / IMPC
- abnormal behavior / IMPC
- decreased circulating cholesterol level / IMPC
- decreased circulating serum albumin level / IMPC
- decreased circulating total protein level / IMPC
- decreased lactate dehydrogenase level / IMPC
- decreased circulating aspartate transaminase level / IMPC
- decreased total body fat amount / IMPC
- decreased bone mineral content / IMPC
B6Brd;B6N-Tyrc-Brd Miga2tm1a(KOMP)Wtsi/Wtsi
Status | Available to order |
EMMA ID | EM:12034 |
International strain name | B6Brd;B6N-Tyrc-Brd Miga2tm1a(KOMP)Wtsi/Wtsi |
Alternative name | EPD0026_1_C12 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Miga2tm1a(KOMP)Wtsi, |
Gene/Transgene symbol | Miga2 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from KOMP ES clone EPD0026_1_C12. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Wellcome Trust Sanger Institute, Hinxton, United Kingdom |
Animals used for archiving | heterozygous C57BL/6Dnk;C57BL/6Brd-Tyr |
Disease and phenotype information
IMPC phenotypes (allele matching)
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).